ID   CDK4_HUMAN              Reviewed;         303 AA.
AC   P11802; O00576; Q6FG61;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   02-NOV-2010, entry version 138.
DE   RecName: Full=Cell division protein kinase 4;
DE            EC=2.7.11.22;
DE   AltName: Full=Cyclin-dependent kinase 4;
DE   AltName: Full=PSK-J3;
GN   Name=CDK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Hanks S.K.;
RL   Submitted (FEB-1987) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=97336055; PubMed=9192850; DOI=10.1006/geno.1997.4727;
RA   Elkahloun A.G., Krizman D.B., Wang Z., Hofmann T.A., Roe B.A.,
RA   Meltzer P.S.;
RT   "Transcript mapping in a 46-kb sequenced region at the core of 12q13.3
RT   amplification in human cancers.";
RL   Genomics 42:295-301(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT CMM3 CYS-24.
RX   MEDLINE=95381067; PubMed=7652577; DOI=10.1126/science.7652577;
RA   Wolfel T., Hauer M., Schneider J., Serrano M., Wolfel C.,
RA   Klehmann-Hieb E., De Plaen E., Hankeln T.,
RA   Meyer Zum Bueschenfelde K.-H., Beach D.;
RT   "A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T
RT   lymphocytes in a human melanoma.";
RL   Science 269:1281-1284(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT CMM3 CYS-24.
RX   MEDLINE=96122049; PubMed=8528263; DOI=10.1038/ng0196-97;
RA   Zuo L., Weger J., Yang Q., Goldstein A.M., Tucker M.A., Walker G.J.,
RA   Hayward N., Dracopoli N.C.;
RT   "Germline mutations in the p16INK4a binding domain of CDK4 in familial
RT   melanoma.";
RL   Nat. Genet. 12:97-99(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-82.
RG   NIEHS SNPs program;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 88-188.
RX   MEDLINE=87092414; PubMed=2948189; DOI=10.1073/pnas.84.2.388;
RA   Hanks S.K.;
RT   "Homology probing: identification of cDNA clones encoding members of
RT   the protein-serine kinase family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:388-392(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 95-182.
RX   MEDLINE=94036854; PubMed=8221695;
RA   Khatib Z.A., Matsushime H., Valentine M., Shapiro D.N., Sherr C.J.,
RA   Look A.T.;
RT   "Coamplification of the CDK4 gene with MDM2 and GLI in human
RT   sarcomas.";
RL   Cancer Res. 53:5535-5541(1993).
RN   [11]
RP   INTERACTION WITH SEI1.
RX   MEDLINE=20047903; PubMed=10580009; DOI=10.1101/gad.13.22.3027;
RA   Sugimoto M., Nakamura T., Ohtani N., Hampson L., Hampson I.N.,
RA   Shimamoto A., Furuichi Y., Okumura K., Niwa S., Taya Y., Hara E.;
RT   "Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-
RT   1).";
RL   Genes Dev. 13:3027-3033(1999).
RN   [12]
RP   INTERACTION WITH ZNF655/VIK.
RX   PubMed=15558030; DOI=10.1038/sj.onc.1208043;
RA   Houlard M., Romero-Portillo F., Germani A., Depaux A.,
RA   Regnier-Ricard F., Gisselbrecht S., Varin-Blank N.;
RT   "Characterization of VIK-1: a new Vav-interacting Kruppel-like
RT   protein.";
RL   Oncogene 24:28-38(2005).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150 AND THR-172, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   VARIANT CMM3 SER-41.
RX   PubMed=9311594;
RX   DOI=10.1002/(SICI)1097-0215(19970904)72:5<780::AID-IJC13>3.0.CO;2-D;
RA   Guldberg P., Kirkin A.F., Gronbaek K., thor Straten P., Ahrenkiel V.,
RA   Zeuthen J.;
RT   "Complete scanning of the CDK4 gene by denaturing gradient gel
RT   electrophoresis: a novel missense mutation but low overall frequency
RT   of mutations in sporadic metastatic malignant melanoma.";
RL   Int. J. Cancer 72:780-783(1997).
RN   [17]
RP   VARIANT CMM3 HIS-24.
RX   MEDLINE=98087572; PubMed=9425228; DOI=10.1093/hmg/7.2.209;
RA   Soufir N., Avril M.-F., Chompret A., Demenais F., Bombled J.,
RA   Spatz A., Stoppa-Lyonnet D., Benard J., Bressac-De Paillerets B.;
RT   "Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone
RT   families in France.";
RL   Hum. Mol. Genet. 7:209-216(1998).
RN   [18]
RP   ERRATUM.
RA   Soufir N., Avril M.-F., Chompret A., Demenais F., Bombled J.,
RA   Spatz A., Stoppa-Lyonnet D., Benard J., Bressac-De Paillerets B.;
RL   Hum. Mol. Genet. 7:941-941(1998).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-122.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probably involved in the control of the cell cycle.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Phosphorylation at Thr-172 is necessary for
CC       enzymatic activity (By similarity).
CC   -!- SUBUNIT: Forms a stable complex with D-type G1 cyclins. Interacts
CC       with CCND1, SEI1 and ZNF655/VIK.
CC   -!- INTERACTION:
CC       Q04323:-; NbExp=1; IntAct=EBI-295644, EBI-1058647;
CC       Q9P1U1:ACTR3B; NbExp=1; IntAct=EBI-295644, EBI-1047175;
CC       P24385:CCND1; NbExp=6; IntAct=EBI-295644, EBI-375001;
CC       P30279:CCND2; NbExp=1; IntAct=EBI-295644, EBI-748789;
CC       P30281:CCND3; NbExp=3; IntAct=EBI-295644, EBI-375013;
CC       Q16543:CDC37; NbExp=4; IntAct=EBI-295644, EBI-295634;
CC       O00311:CDC7; NbExp=1; IntAct=EBI-295644, EBI-374980;
CC       P38936:CDKN1A; NbExp=2; IntAct=EBI-295644, EBI-375077;
CC       P46527:CDKN1B; NbExp=2; IntAct=EBI-295644, EBI-519280;
CC       P49918:CDKN1C; NbExp=1; IntAct=EBI-295644, EBI-519256;
CC       P42771:CDKN2A; NbExp=5; IntAct=EBI-295644, EBI-375053;
CC       P42772:CDKN2B; NbExp=3; IntAct=EBI-295644, EBI-711280;
CC       P42773:CDKN2C; NbExp=1; IntAct=EBI-295644, EBI-711290;
CC       Q9UJU6:DBNL; NbExp=1; IntAct=EBI-295644, EBI-751783;
CC       P57678:GEMIN4; NbExp=1; IntAct=EBI-295644, EBI-356700;
CC       P07948:LYN; NbExp=1; IntAct=EBI-295644, EBI-79452;
CC       P49736:MCM2; NbExp=1; IntAct=EBI-295644, EBI-374819;
CC       P62136:PPP1CA; NbExp=1; IntAct=EBI-295644, EBI-357253;
CC       P36873:PPP1CC; NbExp=1; IntAct=EBI-295644, EBI-356283;
CC       Q9NS64:RPRM; NbExp=1; IntAct=EBI-295644, EBI-1052363;
CC       Q14683:SMC1A; NbExp=1; IntAct=EBI-295644, EBI-80690;
CC       Q9UQE7:SMC3; NbExp=1; IntAct=EBI-295644, EBI-80718;
CC       Q8N720:ZNF655; NbExp=2; IntAct=EBI-295644, EBI-625509;
CC   -!- PTM: Thr-172 is probably phosphorylated by CAK.
CC   -!- DISEASE: Defects in CDK4 are a cause of susceptibility to
CC       cutaneous malignant melanoma type 3 (CMM3) [MIM:609048]. Malignant
CC       melanoma is a malignant neoplasm of melanocytes, arising de novo
CC       or from a pre-existing benign nevus, which occurs most often in
CC       the skin but also may involve other sites.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CDK4ID238ch12q14.html";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/CDK4";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdk4/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14505; AAA35673.1; -; mRNA.
DR   EMBL; U81031; AAC39521.2; -; Genomic_DNA.
DR   EMBL; Z48970; CAA88834.1; -; mRNA.
DR   EMBL; U37022; AAC50506.1; -; Genomic_DNA.
DR   EMBL; AF507942; AAM23014.1; -; Genomic_DNA.
DR   EMBL; CR407668; CAG28596.1; -; mRNA.
DR   EMBL; CR542247; CAG47043.1; -; mRNA.
DR   EMBL; CH471054; EAW97058.1; -; Genomic_DNA.
DR   EMBL; BC003644; AAH03644.1; -; mRNA.
DR   EMBL; BC005864; AAH05864.1; -; mRNA.
DR   EMBL; BC010153; AAH10153.1; -; mRNA.
DR   EMBL; S67448; AAD13991.1; -; Genomic_DNA.
DR   IPI; IPI00007811; -.
DR   PIR; I52695; I52695.
DR   PIR; S52841; S52841.
DR   RefSeq; NP_000066.1; -.
DR   UniGene; Hs.95577; -.
DR   PDB; 1LD2; Model; -; A=1-303.
DR   PDB; 2W96; X-ray; 2.30 A; B=1-303.
DR   PDB; 2W99; X-ray; 2.80 A; B=1-303.
DR   PDB; 2W9F; X-ray; 2.85 A; B=1-303.
DR   PDB; 2W9Z; X-ray; 2.45 A; B=1-303.
DR   PDB; 3G33; X-ray; 3.00 A; A/C=1-303.
DR   PDBsum; 1LD2; -.
DR   PDBsum; 2W96; -.
DR   PDBsum; 2W99; -.
DR   PDBsum; 2W9F; -.
DR   PDBsum; 2W9Z; -.
DR   PDBsum; 3G33; -.
DR   ProteinModelPortal; P11802; -.
DR   DIP; DIP-24211N; -.
DR   DIP; DIP-875N; -.
DR   IntAct; P11802; 79.
DR   MINT; MINT-1201237; -.
DR   STRING; P11802; -.
DR   PhosphoSite; P11802; -.
DR   PRIDE; P11802; -.
DR   Ensembl; ENST00000257904; ENSP00000257904; ENSG00000135446.
DR   GeneID; 1019; -.
DR   KEGG; hsa:1019; -.
DR   UCSC; uc001spv.1; human.
DR   CTD; 1019; -.
DR   GeneCards; GC12M058142; -.
DR   H-InvDB; HIX0010753; -.
DR   HGNC; HGNC:1773; CDK4.
DR   HPA; CAB015153; -.
DR   MIM; 123829; gene.
DR   MIM; 609048; phenotype.
DR   Orphanet; 618; Familial melanoma.
DR   PharmGKB; PA102; -.
DR   eggNOG; prNOG13696; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P11802; -.
DR   OMA; IDQDLRT; -.
DR   OrthoDB; EOG9DNHQB; -.
DR   PhylomeDB; P11802; -.
DR   BRENDA; 2.7.11.22; 247.
DR   Pathway_Interaction_DB; nfat_tfpathway; Calcineurin-regulated NFAT-dependent transcription in lymphocytes.
DR   Pathway_Interaction_DB; foxm1pathway; FOXM1 transcription factor network.
DR   Pathway_Interaction_DB; smad2_3nuclearpathway; Regulation of nuclear SMAD2/3 signaling.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   NextBio; 4283; -.
DR   ArrayExpress; P11802; -.
DR   Bgee; P11802; -.
DR   CleanEx; HS_CDK4; -.
DR   Genevestigator; P11802; -.
DR   GermOnline; ENSG00000135446; Homo sapiens.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme ...; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0048146; P:positive regulation of fibroblast prolifera...; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0042493; P:response to drug; IGI:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Disease mutation; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    303       Cell division protein kinase 4.
FT                                /FTId=PRO_0000085778.
FT   DOMAIN        6    295       Protein kinase.
FT   NP_BIND      12     20       ATP (By similarity).
FT   COMPBIAS     42     48       Poly-Gly.
FT   ACT_SITE    140    140       Proton acceptor (By similarity).
FT   BINDING      35     35       ATP (By similarity).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     150    150       Phosphoserine.
FT   MOD_RES     172    172       Phosphothreonine.
FT   VARIANT      24     24       R -> C (in CMM3; somatic and familial;
FT                                generates a dominant oncogene resistant
FT                                to inhibition by p16(INK4a);
FT                                dbSNP:rs11547328).
FT                                /FTId=VAR_006200.
FT   VARIANT      24     24       R -> H (in CMM3).
FT                                /FTId=VAR_006201.
FT   VARIANT      41     41       N -> S (in CMM3; sporadic).
FT                                /FTId=VAR_021152.
FT   VARIANT      82     82       R -> Q (in dbSNP:rs3211612).
FT                                /FTId=VAR_029153.
FT   VARIANT     122    122       R -> H (in dbSNP:rs34386532).
FT                                /FTId=VAR_041976.
FT   STRAND        7     15
FT   STRAND       18     25
FT   TURN         26     29
FT   STRAND       30     40
FT   TURN         46     48
FT   HELIX        51     66
FT   STRAND       74     81
FT   STRAND       83     94
FT   HELIX       100    104
FT   HELIX       114    133
FT   HELIX       143    145
FT   STRAND      146    148
FT   STRAND      154    156
FT   STRAND      164    166
FT   TURN        168    170
FT   STRAND      173    175
FT   HELIX       176    179
FT   HELIX       183    186
FT   HELIX       194    209
FT   HELIX       219    230
FT   HELIX       235    237
FT   HELIX       246    248
FT   HELIX       257    260
FT   HELIX       266    275
FT   TURN        280    282
FT   HELIX       286    291
FT   TURN        293    295
SQ   SEQUENCE   303 AA;  33730 MW;  0916A0C07403A33A CRC64;
     MATSRYEPVA EIGVGAYGTV YKARDPHSGH FVALKSVRVP NGGGGGGGLP ISTVREVALL
     RRLEAFEHPN VVRLMDVCAT SRTDREIKVT LVFEHVDQDL RTYLDKAPPP GLPAETIKDL
     MRQFLRGLDF LHANCIVHRD LKPENILVTS GGTVKLADFG LARIYSYQMA LTPVVVTLWY
     RAPEVLLQST YATPVDMWSV GCIFAEMFRR KPLFCGNSEA DQLGKIFDLI GLPPEDDWPR
     DVSLPRGAFP PRGPRPVQSV VPEMEESGAQ LLLEMLTFNP HKRISAFRAL QHSYLHKDEG
     NPE
//
